Antonio
Antela López
Universidad de Alcalá
Alcalá de Henares, EspañaPublicacións en colaboración con investigadores/as de Universidad de Alcalá (8)
2021
-
COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study
HIV Medicine, Vol. 22, Núm. 9, pp. 867-876
2018
2014
-
Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries
AIDS, Vol. 28, Núm. 16, pp. 2461-2473
2008
-
Incidence and risk factors for tuberculosis in HIV-positive subjects by HAART status
International Journal of Tuberculosis and Lung Disease, Vol. 12, Núm. 12, pp. 1393-1400
2006
-
Syncytial giant cell hepatitis in human immunodeficiency virus-infected patients with chronic hepatitis C: 2 cases and review of the literature
Human Pathology, Vol. 37, Núm. 10, pp. 1344-1349
-
Viral kinetics and early prediction of nonresponse to peg-IFN-α-2b plus ribavirin in HCV genotypes 1/4 according to HIV serostatus
Journal of Viral Hepatitis, Vol. 13, Núm. 7, pp. 466-473
2005
-
Lipid disorders in antiretroviral-naive patients treated with lopinavir/ritonavir-based HAART: Frequency, characterization and risk factors
Journal of Antimicrobial Chemotherapy, Vol. 55, Núm. 5, pp. 800-804
2004
-
High rate of didanosine-related mitochondrial toxicity in HIV/HCV-coinfected patients receiving ribavirin
Antiviral Therapy, Vol. 9, Núm. 1, pp. 133-138